FSSAI 11th food analyst exam registration window 2025 begins: Direct link to apply here

The Food Safety and Standards Authority of India has opened registrations for the 11th Food Analyst Examination 2025–26, with ...

Upexi Files Shelf Registration Statement on Form S-3 with the U.S. SEC

Announces Plans to Cancel Equity Line Upon S-3 EffectivenessMove to Shelf Registration Statement Enables More Cost-Effective Capital ...

FDA approves Exdensur for severe asthma

The U.S. Food and Drug Administration has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe ...
The Cardiology Advisor

FDA Drug Approval Decisions Expected in January 2026

The FDA is expected to decide on treatments for breast cancer, EBV+ post-transplant lymphoproliferative disease, focal segmental glomerulosclerosis, presbyopia, and severe allergic reactions.
The Manila Times

IN8bio Announces Pricing of Private Placement of up to $40.2 Million to Advance Novel Gamma-Delta T Cell Engager

INB-619, IN8bio’s novel gamma-delta ('γδ”) T cell engager through an Investigational New Drug ('IND”) application ...

How We Created a Tool That Tells You Where Your Generic Drugs Were Made

For decades, the FDA made it nearly impossible to know which factories were manufacturing your generic medications. ProPublica built a tool to show you. Here’s how we did it.

Biofrontera Inc. Completes Transfer of Ameluz® and RhodoLED® FDA approval and Associated Intellectual Property Portfolio

Ameluz® and RhodoLED® New Drug Application (NDA) and Investigational New Drug Application (IND) have successfully been transferred to ...
businessupturn

Aurobindo Pharma’s subsidiary receives US FDA Form 483 with three procedural observations after Telangana facility inspection

Aurobindo Pharma has recently informed exchanges that the United States Food and Drug Administration (US FDA) completed an inspection of Unit-V, the API manufacturing facility of Apitoria Pharma ...
The Manila Times

Moleculin Announces Exercise of Warrants for $6.8 Million Gross Proceeds

Moleculin Biotech, Inc., (Nasdaq: MBRX) ('Moleculin” or the 'Company”), a late-stage pharmaceutical company with a broad ...
Antara News

BPOM launches AI licensing system to amp up drug, food registration

Screenshot - Head of the Indonesian Food and Drug Authority (BPOM) Taruna Ikrar in Jakarta, Friday (November 28, 2025). ANTARA/HO-Badan Pengawas Obat dan Makanan Jakarta (ANTARA) - Indonesia's food ...